Kelley Jane M, Elliott Timothy P, Beddoe Travis, Anderson Glenn, Skuce Philip, Spithill Terry W
Department of Animal, Plant and Soil Sciences and Centre for AgriBioscience, La Trobe University, Bundoora, VIC, Australia.
Veterinary Health Research, Armidale, NSW, Australia.
Trends Parasitol. 2016 Jun;32(6):458-469. doi: 10.1016/j.pt.2016.03.002. Epub 2016 Apr 2.
Triclabendazole (TCBZ) is the only chemical that kills early immature and adult Fasciola hepatica (liver fluke) but widespread resistance to the drug greatly compromises fluke control in livestock and humans. The mode of action of TCBZ and mechanism(s) underlying parasite resistance to the drug are not known. Due to the high prevalence of TCBZ resistance (TCBZ-R), effective management of drug resistance is now critical for sustainable livestock production. Here, we discuss the current status of TCBZ-R in F. hepatica, the global distribution of resistance observed in livestock, the possible mechanism(s) of drug action, the proposed mechanisms and genetic basis of resistance, and the prospects for future control of liver fluke infections using an integrated parasite management (IPM) approach.
三氯苯达唑(TCBZ)是唯一一种能杀死早期未成熟及成虫期肝片吸虫的化学药物,但该药物的广泛耐药性严重影响了对家畜和人类体内吸虫的控制。TCBZ的作用方式以及寄生虫对该药物产生抗性的机制尚不清楚。由于三氯苯达唑耐药性(TCBZ-R)的高流行率,耐药性的有效管理对于可持续畜牧业生产至关重要。在此,我们讨论了肝片吸虫中TCBZ-R的现状、家畜中观察到的耐药性全球分布情况、药物作用的可能机制、耐药性的推测机制和遗传基础,以及使用综合寄生虫管理(IPM)方法未来控制肝吸虫感染的前景。